Features of Top Medical Device Companies

Ora aims to be your one-stop ophthalmology shop

May 21, 2014 by Brad Perriello

The special sauce in contract research organization Ora Inc.'s recipe for ophthalmology trials is the eye care practice its founder started 30 years ago.

Ora aims to be your one-stop ophthalmology shop

There's a special sauce in the recipe Ora Inc. uses to run clinical trials for ophthalmology devices and drugs that can reduce the time needed for a study from 6 months to 2 days: The eye care practice started by Ora founder Dr. Mark Abelson.

An ophthalmologist and optometric scientist and fellow at the Mass. Eye & Ear Infirmary, Abelson founded Andover Eye in 1978, his son Stuart Abelson – now Andover, Mass.-based Ora's CEO – told MassDevice.com.

Animals in labs: PETA's long history with the medtech industry

May 19, 2014 by Arezu Sarvestani

Animal rights advocacy group PETA holds a tiny stake in several medtech companies, taking frequent advantage of its shareholder rights to push changes in the way device makers experiment on animals.

PETA targets Medtronic, Boston Scientific for animal experiments

Animal rights activists have long raised concerns about some of the largest medical device companies, taking up minuscule stock holdings to gain access to shareholder meetings at a raft of medtech makers.

Silicon Valley in-depth: Tapping medtech's Big Data with AliveCor CEO Euan Thomson

May 16, 2014 by Arezu Sarvestani

AliveCor's interim-ish CEO Euan Thomson talks about the data-driven future, why he jumped ship at Accuray and how to navigate the intersection between the tempered medical device world and the wanton nimbleness of Silicon Valley.

In depth in Silicon Valley: Mobile health and medtech's digital future with AliveCor CEO Euan Thomson

When Euan Thomson left Accuray (NSDQ:ARAY) in 2012 after more than 10 years, it wasn't so much for greener pastures as it was for swifter currents.

Medtronic exec: Google looms large as next great rival

May 7, 2014 by Brian Johnson

Medtronic executive Dr. Stephen Oesterle thinks Google will be a force to be reckoned with in the medical technology space in coming years.

Medtronic exec: Google looms large as next great rival

As Medtronic's  (NYSE:MDT) resident technology scout and visionary, Dr. Stephen Oesterle's job is to challenge the status quo at the world's largest pure-play medical device company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Seeing the world through bionic eyes

April 30, 2014 by Brian Johnson

Roger Pontz, 1 of the first recipients of Second Sight Medical's Argus II 'bionic eye,' tells MassDevice.com about how it's changed his life.

Seeing the world through bionic eyes

A version of this story was originally posted on BetaBoston.com

In his hometown of Reed City, Mich., Roger Pontz is a dishwasher in a bowling alley bar. But in medical circles, he's pioneering a new frontier.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Big data and personalized medicine: Q&A with Definiens CEO Thomas Heydler

March 25, 2014 by Chris Walker

Definiens CEO Thomas Heydler discusses his ambition to position his company at the forefront of the coming revolution in personalized and predictive medicines.

MassDevice.com Q&A – Definiens CEO Thomas Hedlyer on personalized medicine

Definiens CEO Thomas Heydler is leading the charge to put his company at the forefront of personalized medicine, starting with a big data approach in order help treat patients.

The imaging software company, started by Nobel Physics prize winner Gerd Binnig, seeks to identify and analyze biomedical images in order to help doctors treat patients as early and efficiently as possible.

The making of an icon | Dr. Tom Fogarty's obsession with innovation

March 21, 2014 by Arezu Sarvestani

Medtech icon Dr. Tom Fogarty tells MassDevice.com about his unconventional path from upstart tinkerer in the suburbs of Cincinnati to healthcare celebrity in the heart of Silicon Valley, in Part 1 of a 3-part series.

The making of an icon | Dr. Tom Fogarty's obsession with innovation

It's been 50 years since Dr. Tom Fogarty invented the catheter-based treatment for blood clots that's now the standard of care. At 80, it would be a cinch for Fogarty to retire to his California vineyard and bask in the reflected glory of his accomplishments.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

DNA sequencing in a handheld laboratory – Q&A with QuantuMDx founder Jonathan O'Halloran

March 17, 2014 by Arezu Sarvestani

QuantuMDx envisions a future where laboratory-quality diagnostics are mobile, cheap and available to everyone, from healthcare providers in developing countries to parents dealing with ill children.

A lab in your pocket – Q&A with QuantuMDx founder Jonathan O'Halloran

QuantuMDx came from humble beginnings, and it's still rather humble now, but the company has a grand vision for the future. With re-imagined diagnostic technology and a burgeoning gene sequencing revolution, QuantuMDx hopes 1 day to see a diagnostic lab in every medicine cabinet and cheap testing that can reach every under-served population.

Medical device tax: At least $510M paid in 2013

March 10, 2014 by Brad Perriello

A MassDevice.com analysis of reported payments for the medical device tax last year finds that 14 companies accounted for more than 97% of the nearly $500 million collected.

Medtech tax tally: At least $510B paid in 2013

UPDATED March 13, 2014, with comment from AdvaMed

The financial impact of the medical device tax appears to be much lower than originally feared, a MassDevice.com analysis shows, with the medtech industry paying at least $500 million on the 2.3% levy last year.

Breathing easier with SinuSys | MassDevice Q&A

March 10, 2014 by Arezu Sarvestani

SinuSys CEO Thomas Schreck and CMO Dr. Jerome Hester tell MassDevice.com how they hope to replace sinus surgery with a simple, in-office procedure and how a doctor and his patient formed a company together.

Breathing easier with SinuSys | MassDevice Q&A

SinuSys executives Thomas Schreck and Dr. Jerome Hester had a very different relationship just 3 years ago. Schreck, a serial entrepreneur now on his 3rd venture, was Hester's patient up until a fateful lunch meeting in Menlo Park, Calif., that led to the founding of SinuSys.

The pair are now busy with the commercial phase of their joint venture, having earlier this year won FDA clearance for the Vent-Os sinus dilation system.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp